Oarsman Capital’s Bio-Techne TECH Stock Holding History

Oarsman Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,253	Closed	-$162K	–	774
2024 Q4	$162K	Buy	2,253 +19	+0.9%	+$1.4K	0.03%	262
2024 Q3	$179K	Buy	+2,234	New	+$168K	0.03%	254

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Oarsman Capital's TECH Position: Q1 2025 in Review

Oarsman Capital sold out of Bio-Techne (TECH) in Q1 2025, closing a stake of 2,253 shares — an estimated $162K sold.

Oarsman Capital first reported a position in TECH in Q3 2024 and held it in 2 quarters. The position peaked at $179K in Q3 2024. 577 funds tracked by Wall St. Rank hold TECH as of Q1 2025.

Oarsman Capital reported no remaining Bio-Techne position as of Q1 2025 after selling out during the quarter.
Oarsman Capital sold 2,253 Bio-Techne shares in Q1 2025, an estimated $162K.
Oarsman Capital first reported a position in Bio-Techne in Q3 2024 and held it in 2 quarters.
Oarsman Capital's Bio-Techne position peaked at $179K in Q3 2024.
577 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.